As always, the man from Masimo has strong words. Apple has replied. The firm claims that the blood oxygen sensor is accurate, and that, in essence, Kiani isn’t telling the truth. The difference ...

It was really about the O2 sensor patent infringement case Masimo brought against Apple. In theory, that’s a completely unrelated case. In practice, not so much. If you need a quick recap ...

Note that the Masimo trade secret lawsuit against Apple is separate from both an ITC injunction preventing the sale of Apple Watch models with a blood oxygen sensor and a patent infringement case ...

New features like the Tides App on the Watch Ultra 2 probably don't get as the still-missing pulse oximetry sensing. © Photo: Florence Ion / Gizmodo For most regular ...

Apple and Masimo's patent and trade secret dispute has ... excluding Apple Watches with a blood oxygen sensor. Apple redesigned and got Customs approval to continue sales by January 2024.

A Delaware jury has found smartwatch maker Masimo guilty of infringing Apple's Apple Watch patents on health technology, but ...

A Delaware jury has ruled in favor of Apple in a patent infringement case against Masimo, awarding Cupertino a symbolic $250 ...

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its ...

Apple convinced a federal jury on Friday that health monitoring tech company Masimo’s smartwatches infringe two of its design patents. The jury, in Delaware, agreed with Apple that Masimo ...

Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2024-11-05. Here's what investors need to know before the announcement. Analysts estimate that Masimo will ...

Masimo MASI2.20%increase; green up pointing triangle said Joe Kiani, who previously informed the board of his decision to resign as chief executive, has been terminated by the company. Kiani’s ...

Masimo stock jumped Wednesday after Chief Executive Joe Kiani resigned, while the company's other executives stayed on board.